Study, Evaluating Pharmacokinetics, Immunogenicity and Safety Profiles of Pertuzumab Compared to Perjeta® in Healthy Man
Clinical trial NCT05825781 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05825781
- Sponsor
- Mabscale, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-20
- Primary completion
- 2024-01-22
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.